FindTrial
Sign In

To Study the Effect of Homoeopathic Medicine in Treatment of Insomnia Among Adults

Effectiveness of Individualised Homoeopathic Medicine in Management of Insomnia among Adults An Experimental Non Controlled Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095668
Enrollment
42
Registered
2025-10-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G470- Insomnia

Interventions

Intervention1: EFFECTIVENESS OF INDIVIDUALISED HOMOEOPATHIC MEDICINE IN MANAGEMENT OF INSOMNIA AMONG ADULTS: AN EXPERIMENTAL NON-CONTROLLED STUDY.: The Pre and Post Athens Insomnia Scale Score is calc

Sponsors

Dr Kajal Madhavi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a Patients above the age of 18 year. b Patients clinically diagnosed with Transient, Acute and Chronic Insomnia as per DSM-V Criteria. c Symptoms of Insomnia as diagnosed by the DSM-5 Criteria for Insomnia Disorder specifically: Difficulty initiating or maintaining sleep or waking up too early for at least 3 nights per week, for at least 3 months, with adequate opportunity and circumstances for sleep and at least one daytime impairment related to the sleep difficulty d Never previously treated with CBT-I. e At least one-month Anti-hypnotic free and willing to not take Anti-hypnotics f Patients willing to give Informed Written consent

Exclusion criteria

Exclusion criteria: a Patients suffering from past or present seizure disorder; a history of psychosis, depression or mania; current mood disorder; or a clinically significant head trauma b Shift workers who rotate to night shift c Restless legs Syndrome d Suspected Immunocompromised patients e Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Outcome will be assessed in terms of 1 Improved 2 Not improved These criteria will be assessed as per the score of AIS. Timepoint: 1 Duration of study - 18 months 2 Duration of each case- Each case will be studied for 8 months or till relief of symptoms. 3 Duration of follow up- Each case will be followed up after 15 days or as and when required. 4 Clinical Outcome assessment will be done at baseline, 1 month, 3 months, 6 months and at termination of treatment—

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable—

Countries

India

Contacts

Public ContactDr Chintan Mehta

Dr G D Pol Foundation YMT Homoeopathic Medical College Hospital and PG Institute

swati_bhagwat_29@yahoo.co.in9969337242

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026